Improve Colorectal Cancer Prevention by Motivational and Community-based Approaches

Sponsor
Centre Leon Berard (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05568667
Collaborator
(none)
90
1
1
8
11.3

Study Details

Study Description

Brief Summary

It has been estimated that 19,000 Colorectal Cancers (CRC) could be prevented each year in France by changing individual risk behaviours (sedentary lifestyle, overweight, diet, alcohol). The cancer screening appears to be an opportune moment for health promotion and to inform about CRC risk factors.

The PRECÔTION study proposes an innovative scheme based on informative, motivational and community-based approaches. The objectives are to take advantage of patients' visits for colonoscopy to raise awareness and initiate individual prevention actions according to their own risk in order to modify individual risk behaviour.

Patients who come for a colonoscopy at the Centre Léon Bérard and who are negative (80% of cases) will benefit from an evaluation to identify their individual risk factors, determine their level of risk level for CRC and their motivation to change their behaviour.

Participants with a low level of risk will receive remote support in physical activity and nutrition via digital media based on a motivational approach. Participants will be proposed a monthly collective physical activity session, which will allow them to interact with each other and develop a community approach. Participants with an intermediate level of risk will be offered a collective health education session, in addition to the the support offered to participants with a low level of risk. Participants with a high level of risk will receive, in addition to the the support offered to participants with an intermediate level of risk, an individual motivational coaching and a connected watch. A logbook will also be given to all participants to accompany them on the different tools, especially for monitoring their goals.

The PRECÔTION study aims to evaluate these tools as innovative means of prevention before evaluate their effectiveness on a larger scale.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Low risk
  • Behavioral: Moderate risk
  • Behavioral: High risk
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Pilot Study to Improve Primary Prevention of Colorectal Cancer by Motivational and Community-based Approaches, According to Individual Risk Level, in People Undergoing Colonoscopy
Anticipated Study Start Date :
Oct 17, 2022
Anticipated Primary Completion Date :
Jun 17, 2023
Anticipated Study Completion Date :
Jun 17, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Risk sub-group

st sub-grouup : Low risk to develop a CRC nd sub-group : Moderate risk to develop a CRC rd sub-group : High risk to develop a CRC

Behavioral: Low risk
remote support in physical activity and nutrition via digital media monthly collective physical activity sessions logbook

Behavioral: Moderate risk
remote support in physical activity and nutrition via digital media monthly collective physical activity sessions one collective health education session logbook

Behavioral: High risk
remote support in physical activity and nutrition via digital media monthly collective physical activity sessions one collective health education session 3 individual sessions of motivational coaching connected watch logbook

Outcome Measures

Primary Outcome Measures

  1. Assessment of the programme feasability [Month 6]

    Participation rate at each modality of the programme

Secondary Outcome Measures

  1. Assessment of the programme acceptability [Month 6]

    Participation rate to the study (number of participants/number of eligible persons)

  2. Assessment of the programme acceptability [Month 6]

    Satisfaction, assessed by a Likert scale on a self-administered questionnaire

  3. Assessment of the programme observance [Month 6]

    Evaluate the observance to the whole programme, for each subgroup

  4. Assessment of the evolution of lifestyle [Month 6]

    World Cancer Research Fund international questionnaire Score : from 0 (worse score) to 7 (better score)

  5. Assessment of the physical activity level change [Month 6]

    Evaluate the effects on physical activity level using the IPAQ

  6. Assessment of the evolution on CRC risk factors knowledge [Month 6]

    Self-administered questionnaire (questionnaire specially designed for the study, no titlle) Score : from 0 (worse score) to 9 (better score)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • I1. Adult aged ≤ 80 years,

  • I2. Having undergone in the month prior to inclusion a colonoscopy for CRC screening, with a negative result,

  • I3. Willing to be involved throughout the study,

  • I4. Able to practice a adapted physical activity (APA) certified by a medical certificate issued by the referring oncologist or the clinical investigator,

  • I5. Using a own smartphone, a tablet or a PC with Internet connexion,

  • I6. Having a valid health insurance affiliation,

  • I7. Having dated and signed an informed consent form,

  • I8. Able to read, write and understand French.

Exclusion Criteria:
  • NI1. Presence of a primary cancer (other than in situ cancer of any location and/or basal cell skin cancer) - NB : people in complete remission from a previous cancer may be included,

  • NI2. With a contraindication to pratice physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease),

  • NI3. Severe undernutrition (HAS) (i.e. weight loss ≥ 10% in 1 month or ≥ 15% in 6 months or ≥ 15% compared to usual weight or body mass index ≤ 17 kg/m² for a person < 70 ans or body mass index < 20 kg/m² for a person ≥ 70 ans)

  • NI4. Unable to be followed for medical, social, family, geographical or psychological reasons throughout the study,

  • NI5. Deprived of liberty by judicial or administrative decision,

  • NI6. Concurrent participation in another PA or nutrition study,

  • NI7. (For women) Pregnant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Léon Bérard (CLB) Lyon France 69008

Sponsors and Collaborators

  • Centre Leon Berard

Investigators

  • Principal Investigator: Anne CATTEY-JAVOUHEY, MD, PhD, Centre Leon Berard

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Leon Berard
ClinicalTrials.gov Identifier:
NCT05568667
Other Study ID Numbers:
  • PRECÔTION
First Posted:
Oct 6, 2022
Last Update Posted:
Oct 7, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 7, 2022